Abstract
We read with interest the article on the use of statins for patients with pneumonia.1 Although an important addition to the literature, several issues limit this article's usefulness. The choice of an outcome measure combining in-hospital mortality and admission to intensive care is curious for a prospective study with such a rich clinical database. Previous research shows that 30 day mortality …